Ablexis
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
10350 Barnes Canyon Rd Ste 100, San Dieg...Phone Number
(415) 967-1220Website
www.ablexis.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Ablexis
Ablexis offers a next generation transgenic mouse platform designed for the efficient discovery and development of therapeutic antibodies. Their technology provides expanded immune responses with the AlivaMab-X Mouse, making it a leading choice in the industry. The company also provides tailored licensing options to meet the diverse needs of its partners. Intended clients include pharmaceutical and biotechnology companies focused on antibody and antibody-derivative drug candidates.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ablexis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Ablexis is spiking on competitors!
Product Launch: Get notified when Ablexis launches new products
Ablexis, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Ablexis has recently received funding, and reach out quickly before it becomes old news!
Click to see if Ablexis had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Ablexis
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Ablexis has new funding data
Earning: See what the market has to say on Ablexis recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Ablexis
Find more new buyers
Compare Similar Companies to Ablexis
Compare insights from companies similar to Ablexis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ablexis
<$5M
1-10
Private
$12M
2009
N/A
Company Profile Activity
Activity Insights
Ablexis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ablexis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ablexis.
Ablexis financials insights
Gather financial insights about Ablexis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Series A
$12M
Ablexis Tech Stack
A closer look at the technologies used by Ablexis
Most Recent Scoops
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Event
Events
Ablexis News & Media
Ablexis and AlivaMab Discovery Services Announce Expansion of Antibody Drug Discovery and Engineering Capabilities
SAN DIEGO--(BUSINESS WIRE)--Ablexis and AlivaMab Discovery Services Announce Expansion of Antibody Drug Discovery and Engineering CapabilitiesAblexis and AlivaMab Discovery Services Announce Agreements with Almirall to Accelerate Antibody Drug Discovery and Development
SAN DIEGO, Calif. & BARCELONA, Spain--(BUSINESS WIRE)--AlivaMab Discovery Sevices and Ablexis, have partnered with Almirall to discover new therapeutic antibodies for severe dermatological conditions.Ablexis Announces Multi-Target License Agreement with Tanabe Research Laboratories U.S.A.
SAN DIEGO--(BUSINESS WIRE)--Ablexis Announces Multi-Target License Agreement with Tanabe Research Laboratories U.S.A.Ablexis Announces Further Expansion of Its Intellectual Property on AlivaMab® Mouse and Immunoglobulin Locus Engineering
SAN DIEGO--(BUSINESS WIRE)--Ablexis, LLC, a biopharmaceutical company focused on licensing its transgenic mouse platforms for antibody drug discovery, today announced further expansion of its intellectual property portfolio directed to its AlivaMab Mouse platform and its groundbreaking insights into the design and engineering of well-functioning immunoglobulin transgenes for antibody drug discovery and development. The expanded portfolio includes recently issued United States patents 10,492,476
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Ablexis
Sign Up For FreeTo access detailed company insights
Ablexis offers a next generation transgenic mouse platform designed for the efficient discovery and development of therapeutic antibodies. Their technology provides expanded immune responses with the AlivaMab-X Mouse, making it a leading choice in the industry. The company also provides tailored licensing options to meet the diverse needs of its pa... Read More
